- Home
- REE vs ACHV Comparison
REE vs ACHV Comparison
Compare REE & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- ACHV
- Stock Information
- Founded
- REE 2011
- ACHV N/A
- Country
- REE Israel
- ACHV Canada
- Employees
- REE N/A
- ACHV N/A
- Industry
- REE Auto Manufacturing
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- REE Consumer Discretionary
- ACHV Health Care
- Exchange
- REE Nasdaq
- ACHV Nasdaq
- Market Cap
- REE 153.8M
- ACHV 159.0M
- IPO Year
- REE N/A
- ACHV N/A
- Fundamental
- Price
- REE $6.94
- ACHV $4.25
- Analyst Decision
- REE Buy
- ACHV Strong Buy
- Analyst Count
- REE 4
- ACHV 5
- Target Price
- REE $9.25
- ACHV $14.80
- AVG Volume (30 Days)
- REE 57.0K
- ACHV 112.1K
- Earning Date
- REE 11-29-2024
- ACHV 11-07-2024
- Dividend Yield
- REE N/A
- ACHV N/A
- EPS Growth
- REE N/A
- ACHV N/A
- EPS
- REE N/A
- ACHV N/A
- Revenue
- REE $825,000.00
- ACHV N/A
- Revenue This Year
- REE N/A
- ACHV N/A
- Revenue Next Year
- REE $50,620.25
- ACHV N/A
- P/E Ratio
- REE N/A
- ACHV N/A
- Revenue Growth
- REE N/A
- ACHV N/A
- 52 Week Low
- REE $2.91
- ACHV $3.03
- 52 Week High
- REE $8.79
- ACHV $5.98
- Technical
- Relative Strength Index (RSI)
- REE 45.93
- ACHV 35.58
- Support Level
- REE $7.00
- ACHV $4.32
- Resistance Level
- REE $8.79
- ACHV $4.75
- Average True Range (ATR)
- REE 0.56
- ACHV 0.23
- MACD
- REE -0.12
- ACHV -0.06
- Stochastic Oscillator
- REE 6.78
- ACHV 9.40
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.